Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ASUXFOTCMKTS:CLIGFOTCMKTS:ELMTYOTCMKTS:RDEIY On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeASUXFAmerisur Resources$0.24+0.4%$0.24$0.13▼$0.28$292.93M1.236 shs100 shsCLIGFClinigen Group$8.02$8.02$8.02▼$11.56$1.07B0.498,620 shsN/AELMTYElementis$7.20$7.24$7.10▼$7.35$1.06B0.77100 shsN/ARDEIYRedeia Corporación$10.87+0.4%$9.81$8.03▼$11.50$1.18B0.5453,550 shs26,417 shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceASUXFAmerisur Resources0.00%0.00%0.00%0.00%0.00%CLIGFClinigen Group0.00%0.00%0.00%0.00%0.00%ELMTYElementis0.00%0.00%0.00%-2.04%-3.74%RDEIYRedeia Corporación+0.37%-0.28%+12.18%+32.56%+28.64%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationASUXFAmerisur ResourcesN/AN/AN/AN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AN/AN/AN/AELMTYElementisN/AN/AN/AN/AN/AN/AN/AN/ARDEIYRedeia CorporaciónN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceASUXFAmerisur Resources 0.00N/AN/AN/ACLIGFClinigen Group 0.00N/AN/AN/AELMTYElementis 4.00Strong BuyN/AN/ARDEIYRedeia Corporación 2.50Moderate BuyN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookASUXFAmerisur ResourcesN/AN/AN/AN/AN/AN/ACLIGFClinigen Group$704.71M1.51$1.43 per share5.60$4.52 per share1.77ELMTYElementis$713.40M1.49$0.80 per share8.99$5.77 per share1.25RDEIYRedeia Corporación$2.23B0.53$1.46 per share7.43N/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateASUXFAmerisur ResourcesN/AN/A0.00∞N/AN/AN/AN/AN/ACLIGFClinigen Group$40.78MN/A0.00∞N/AN/AN/AN/AN/AELMTYElementis$26.50MN/A0.0013.33N/AN/AN/AN/AN/ARDEIYRedeia Corporación$746.33MN/A0.00∞N/AN/AN/AN/A4/30/2025 (Estimated)Compare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthASUXFAmerisur ResourcesN/AN/AN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AN/AN/AELMTYElementis$0.182.50%N/AN/AN/ARDEIYRedeia Corporación$0.121.10%N/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioASUXFAmerisur ResourcesN/AN/AN/ACLIGFClinigen GroupN/AN/AN/AELMTYElementis0.332.321.29RDEIYRedeia CorporaciónN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipASUXFAmerisur ResourcesN/ACLIGFClinigen GroupN/AELMTYElementisN/ARDEIYRedeia CorporaciónN/AInsider OwnershipCompanyInsider OwnershipASUXFAmerisur ResourcesN/ACLIGFClinigen GroupN/AELMTYElementisN/ARDEIYRedeia CorporaciónN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableASUXFAmerisur Resources831.22 billionN/ANot OptionableCLIGFClinigen Group1,069133.03 millionN/ANot OptionableELMTYElementis1,281147.74 millionN/ANot OptionableRDEIYRedeia Corporación2,464108.22 millionN/ANot OptionableASUXF, RDEIY, CLIGF, and ELMTY HeadlinesRecent News About These CompaniesRedeia Corporación (OTCMKTS:RDEIY) Share Price Crosses Above 50 Day Moving Average - Should You Sell?April 24 at 6:30 AM | marketbeat.comRedeia Corporación, S.A. (OTCMKTS:RDEIY) Short Interest Up 490.3% in MarchApril 16, 2025 | marketbeat.comRedeia Corporación (OTCMKTS:RDEIY) Reaches New 12-Month High - Here's WhyApril 16, 2025 | marketbeat.comRedeia Corporación (OTCMKTS:RDEIY) Shares Cross Above 50-Day Moving Average - Here's What HappenedApril 12, 2025 | marketbeat.comRedeia Corporación (OTCMKTS:RDEIY) Hits New 52-Week High - Time to Buy?April 4, 2025 | marketbeat.comRedeia Corporación (OTCMKTS:RDEIY) Reaches New 12-Month High - Should You Buy?March 28, 2025 | marketbeat.comRedeia Corporación, S.A. (OTCMKTS:RDEIY) Short Interest UpdateMarch 27, 2025 | marketbeat.comRedeia Corporación, S.A. (RDEIF) Q4 2024 Earnings Conference Call TranscriptFebruary 28, 2025 | seekingalpha.comIndra compra el 89% de Hispasat a Redeia por 725 millones de eurosFebruary 2, 2025 | heraldo.esIndra compra el 89,68% de Hispasat por 725 millones de eurosFebruary 2, 2025 | bolsamania.comIndra se hace con el control de HispasatFebruary 2, 2025 | publico.esRedeia Corporación, S.A. goes ex dividend MondayJanuary 3, 2025 | msn.comRedeia destina casi 7 millones a más de 107 iniciativas sociales y ambientalesOctober 18, 2024 | infobae.comREDEIA: Estos son los motivos por los que hay que comprar.August 13, 2024 | bolsamania.comRedeia Corporacion (REDE)August 6, 2024 | es.investing.comRBC Capital Remains a Buy on Red Electrica Corporacion (0RI5)August 4, 2024 | markets.businessinsider.comRedeia Corporación, S.A. (RDEIF)July 31, 2024 | finance.yahoo.comNaturgy Energy Group S.A. (NTGY)May 22, 2024 | es.investing.comRDEIF Redeia Corporación, S.A.May 3, 2024 | seekingalpha.comRed Electrica Corporacion SA ADR (RDEIY)February 23, 2024 | es.investing.comRedeia Corporación: Scaling The Business Resulting In Falling ReturnsJanuary 18, 2024 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeASUXF, RDEIY, CLIGF, and ELMTY Company DescriptionsAmerisur Resources OTCMKTS:ASUXF$0.24 +0.00 (+0.42%) As of 01/6/2020Amerisur Resources plc engages in exploration and production of oil and gas assets in Colombia and Paraguay. It has assets around the OBA pipeline and also across the wider Putumayo region, with 11 blocks in total covering 984,000 hectares gross. Amerisur Resources Plc was incorporated in 2000 and is based in Cardiff, the United Kingdom.Clinigen Group OTCMKTS:CLIGF$8.02 0.00 (0.00%) As of 03/24/2023Clinigen Group plc operates as a pharmaceutical and services company in the United Kingdom, rest of Europe, the United States, South Africa, Australia, and internationally. It operates through Services and Products divisions. The company provides a set of niche and high value services to pharma and biotech clients prior to product launch. It also provides access to critical medicines around the world for patients with unmet needs. In addition, the company provides a portfolio of specialist medicines to service the needs of healthcare professionals and their patients in both licensed and unlicensed markets. Further, it offers Nortriptyline Colonis for the treatment of depressive disorder; Metformin Colonis for the treatment of type 2 diabetes mellitus; Magnesium Chewable Tablets, an oral magnesium supplements for the treatment of patients with chronic magnesium loss; Iloprost, a concentrate for solution for infusion; Glycopyrronium Bromide, an oral solution for the treatment of severe sialorrhoea; Acetylcysteine, an oral solution for the treatment of respiratory disorders associated with thick, viscous, and mucus hypersecretion; Cardioxane that protects the heart against the cardiotoxic effects of anthracyclines; Ethyol, which protect against the harmful effects of chemotherapy medications and radiation treatment; Proleukin for the treatment of kidney cancer; Imukin that is used in chronic granulomatous disease; Totect, a dexrazoxane product; Foscavir, an anti-virals that work by stopping viruses from multiplying in number; and Savene, which is indicated in adults for the treatment of anthracycline extravasation. The company was incorporated in 2008 and is headquartered in Burton-on-Trent, the United Kingdom.Elementis OTCMKTS:ELMTY$7.20 0.00 (0.00%) As of 04/25/2025Elementis plc operates as a specialty chemical company in the United Kingdom, rest of Europe, North America, and internationally. It operates in two segments, Performance Specialties and Personal Care. The Performance Specialties segment engages in the production of rheological modifiers and additives for decorative and industrial coatings; and production and supply of talc for use in plastics, coatings, technical ceramics, and paper sectors. The Personal Care segment provides rheological modifiers and compounded products, including active ingredients for antiperspirants (AP) deodorants for personal care manufacturers. The company offers personal care products for antiperspirants, color cosmetics, and skin care applications; and performance specialties products for architectural coatings, adhesives, sealants and construction additives, and talc applications. Elementis plc was founded in 1844 and is headquartered in London, the United Kingdom.Redeia Corporación OTCMKTS:RDEIY$10.87 +0.04 (+0.37%) As of 04/25/2025 03:58 PM EasternRedeia Corporación, S.A. engages in the electricity transmission, and system operation and management of the transmission network for the electricity system in Spain and internationally. The company operates through three segments: Management and Operation of National Electricity Infrastructure; Management and Operation of International Electricity Infrastructure; and Telecommunications (Satellites and Fibre Optic). Its transmission network comprises approximately 45,141 kilometres; and has 94,981 MVA of transformation capacity. The company also provides advisory, engineering, and construction services; and telecommunications, financing, reinsurance, line and substation maintenance, technical consultancy, and satellite telecommunications services. In addition, it manages and constructs energy storage facilities and the water cycle; acquires, holds, manages, and administers equity securities; operates satellite communications system and provides space segment services for the geostationary orbital slots; and sells and leases satellites and spatial capacity. The company was formerly known as Red Eléctrica Corporación, S.A. and changed its name to Redeia Corporación, S.A. in June 2023. Redeia Corporación, S.A. was incorporated in 1985 and is based in Alcobendas, Spain. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/21 - 04/25 Bears Can Reap Big Benefits With These 3 Short ETF Bets If You Wanted To Buy AbbVie and Didn’t, There’s Still Time To Buy 3 Stocks To Watch For When Tariffs Subside 3 Boring Stocks Outperforming the Market This Year Short Sellers Gave Up on These 3 Names Recently Churchill Downs Stock: Could Tariff Fears Dampen Derby Gains? Markets Think Robinhood Earnings Could Send the Stock Up Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
